Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Pacritinib Versus Best Available Therapy to Treat Patients With Myelofibrosis and Thrombocytopenia

ClinicalTrials.gov ID: NCT02055781

Public ClinicalTrials.gov record NCT02055781. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Controlled Phase 3 Study of Oral Pacritinib Versus Best Available Therapy in Patients With Thrombocytopenia and Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis

Study identification

NCT ID
NCT02055781
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
CTI BioPharma
Industry
Enrollment
311 participants

Conditions and interventions

Interventions

  • Pacritinib Drug
  • Best Available Therapy Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2014
Primary completion
Mar 31, 2016
Completion
Mar 31, 2016
Last update posted
Nov 17, 2021

2014 – 2016

United States locations

U.S. sites
50
U.S. states
25
U.S. cities
45
Facility City State ZIP Site status
Mayo Clinic Arizona Scottsdale Arizona 85259
Arizona Clinical Research Center Tucson Arizona 85715
City of Hope Duarte California 91010
Moores Cancer Centre La Jolla California 92093
USC Norris Comprehensive Cancer Center Los Angeles California 90033
Stanford Cancer Center Stanford California 94305
Rocky Mountain Cancer Center Boulder Colorado 80303
George Washington University- Medical Faculty Associates Washington D.C. District of Columbia 20037
SCRI- Florida Cancer Specialists South Region Fort Myers Florida 33916
SCRI - Florida Cancer Specialists North Region St. Petersburg Florida 33705
H. Lee Moffitt Cancer Center & Research Institute Tampa Florida 33612
Northwestern University Chicago Illinois 60611
Carle Cancer Center Urbana Illinois 61801
Indiana University Goshen Cancer Centre Goshen Indiana 46526
Investigative Clinical Research of Indiana Indianapolis Indiana 46260
University of Iowa Hospitals and Clinics Iowa City Iowa 52242
Siouxland Hematology-Oncology Associates, L.L.P (SHOA) Sioux City Iowa 51101
Norton Cancer Institute, Suburban Louisville Kentucky 40207
St Joseph Mercy Hospital Ann Arbor Michigan 48106
University of Michigan Ann Arbor Michigan 48109
Henry Ford Health System Detroit Michigan 48202
Providence Cancer Institute Southfield Michigan 48075
Washington University School of Medicine Division of Oncology St Louis Missouri 63110
Nebraska Hematology-Oncology, P.C. Lincoln Nebraska 68506
Hackensack University Hackensack New Jersey 07601
Hematology-Oncology Associates of Northern Jersey Morristown New Jersey 07962
New Mexico Cancer Care Alliance Albuquerque New Mexico 87106
Mount Sinai Medical Center New York New York 10029
Columbia University Medical Center New York New York 10032
Stony Brook University Medical Center Stony Brook New York 11794
SCRI-Oncology Hematology Care Cincinnati Ohio 45242
Cleveland Clinic-Taussig Cancer Center Cleveland Ohio 44195
University of Oklahoma Oklahoma City Oklahoma 73104
Thomas Jefferson University Philadelphia Pennsylvania 19107
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232
Upstate Oncology Associates Greenville South Carolina 29601
Sarah Cannon Research Institute (SCRI) Nashville Tennessee 37203
Texas Onocolgy-Baylor Sammons Cancer Center Dallas Texas 75246
UT Southwestern Medical Center Dallas Texas 75390
UTMB Galveston Galveston Texas 77555
Houston Methodist Houston Texas 77030
University of Texas MD Anderson Cancer Center Houston Texas 77030
Cancer Care Centers of South Texas San Antonio Texas 78229
Huntsman Cancer Hospital Salt Lake City Utah 84112
Virginia Cancer Specialists Leesburg Virginia 20176
Providence Regional Cancer Partnership Everett Washington 98201
Fred Hutchinson Cancer Research Center Seattle Washington 98109
Green Bay Oncology Green Bay Wisconsin 54301
Froedtert Hospital and the Medical College of Wisconsin Milwaukee Wisconsin 53226
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 72 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02055781, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 17, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02055781 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →